A Study to Evaluate Safety and Feasibility of Robotic Liver Resection
1 other identifier
interventional
1,000
1 country
1
Brief Summary
The robotic surgery system, the most advanced technology in minimally invasive surgery, overcame some shortcomings of laparoscopic surgery and improved the flexibility and precision of liver resection. Several studies have demonstrated that the robotic system was safe and feasible in liver surgery and might be advantageous in complex hepatic vein and hilar dissection, operative bleeding control, and biliary reconstruction. Previous comparative studies found limited evidence for significantly improved outcomes in robotic liver resection (RLR) over laparoscopic liver resection (LLR) or open liver resection (OLR), considering the various degrees of difficulty in liver surgeries. This study aimed to evaluate safety and feasibility of robotic liver resection, by comparing it with LLR or OLR, and gain veritable and relevant data on the benefits of RLR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedFirst Submitted
Initial submission to the registry
March 26, 2024
CompletedFirst Posted
Study publicly available on registry
April 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedApril 9, 2024
April 1, 2024
5.1 years
March 26, 2024
April 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postoperative complications
The grades of postoperative complications were recorded following the Clavien-Dindo classification. Partial hepatic dysfunction or hepatic failure, biliary fistula, postoperative hemorrhage, pleural effusion, venous thrombosis, and surgical site infections were recorded.
with in 90 days after surgery
Postoperative hospital stay
The days of hospital stay after operation
with in 90 days after surgery
Postoperative unplanned reoperation
The unplanned reoperation due to postoperative complications
with in 90 days after surgery
Unplanned readmission
The unplanned readmission after discharge due to postoperative complications
with in 90 days after surgery
Study Arms (1)
Robotic liver resection
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- The patients were diagnosed with a liver tumor.
- The patients underwent robotic liver resection.
You may not qualify if:
- The patients underwent simultaneous malignancy resection of the colorectum or other organs (except gallbladder).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital, Medical College of Zhejiang University
Hangzhou, Zhejiang, 310003, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 26, 2024
First Posted
April 9, 2024
Study Start
December 1, 2020
Primary Completion
December 31, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
April 9, 2024
Record last verified: 2024-04